Piramal Pharma releases Sustainability Report FY 2023-24
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
The inspection conducted by EDQM at its Visakhapatnam facility
He holds a Master’s in Management from the National University of Singapore
The net-zero target approval complements the company's near-term emission reduction targets
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
India has taken the lead in recognising NAFLD as a major non-communicable disease
Subscribe To Our Newsletter & Stay Updated